You are three weeks from confirmatory diligence, the deal team wants a commercial read on a target that grew 40% for two years running, and you have to decide who does the work. The management growth story is clean on the surface. The question that actually decides the deal is whether that growth was pipeline the business built or a handful of accounts a founder-led sales motion cannot repeat. Pick the wrong commercial due diligence firm and you get a well-formatted deck that restates the CIM, misses the concentration risk, and lands after the price is already set. Pick the right one and you walk into the investment committee with an independent view of demand, competitive position, and whether the plan you are underwriting survives contact with the market.
This guide is for the operating partner, deal lead, or portfolio-company CEO who has budget and a live decision, not for someone learning what commercial diligence is. The goal here is narrow and practical: what a commercial due diligence firm in private equity actually needs to deliver, how to scope it so it informs the price and the plan, and how to tell a rigorous provider from an expensive one before you sign the engagement letter.
1. Start with the commercial decision the report has to inform
Commercial diligence is not a checkbox. It exists to answer questions that move price, structure, or the value-creation plan. Before you talk to a single firm, write down the two or three decisions you need the work to inform. In my experience the vendors who ask for this list first are the ones worth hiring; the ones who send a standard scope regardless of the asset are selling a template.
Typical decisions a commercial read should sharpen:
- Is the growth thesis real and repeatable? Demand durability, win rates, sales-cycle behavior, and whether the pipeline reflects a system or a personality.
- Is the market big enough and moving the right direction? Serviceable market, share, and the growth vector you are underwriting.
- How exposed is the revenue base? Customer concentration, churn, net revenue retention, contract terms, and pricing power.
- Does the plan hold? Whether the sponsor’s revenue model in the base case is supported by evidence or by hope.
Bain’s annual private equity report has documented for years how value creation has shifted from financial engineering and multiple expansion toward operational and revenue improvement (Bain & Company Global Private Equity Report). That shift is exactly why a commercial read now has to do more than confirm the market exists. It has to tell you where the plan’s revenue actually comes from, because in most deals the return depends on it.
2. Separate market study from commercial due diligence
Buyers conflate these two, and firms are happy to let them, because a market study is easier to produce. A market study describes the size, growth, segmentation, and competitive structure of a category. Useful, but it does not tell you whether this company can win in it.
Commercial due diligence connects the outside-in market view to the inside-out reality of the target: its actual pipeline, its win/loss record, its customer economics, its go-to-market machinery. The first tells you the pond is stocked. The second tells you whether the target can fish.
When you scope the engagement, insist the firm treat the target’s own data as primary evidence, not as a footnote to a market model. If a provider’s proposal is 80% secondary market research and 20% target-specific analysis, you are buying a market study with a diligence label. That gap is where deals get repriced after close, not before.
The evidence hierarchy a good firm works from
Rank the sources of confidence, highest to lowest:
- Target’s own transactional data: CRM records, invoiced revenue, cohort retention, contract data. Hard to fake, hard to spin.
- Primary customer references: structured interviews with current, churned, and lost customers.
- Competitor and channel interviews: outside-in reads on where the target actually sits.
- Management assertions: useful as hypotheses, never as conclusions.
- Secondary market reports: context and sizing, not proof of the thesis.
The best firms weight the top of that list. The weakest lead with the bottom.
3. Define the scope against the specific deal thesis
A generic commercial diligence scope is a red flag. The work should be tailored to the sponsor’s thesis and the asset’s shape. A carve-out from a corporate parent raises different commercial questions than a founder-owned business or a platform buying its fifth add-on.
Match the scope to the deal type
- Platform buyout: is the core demand durable, is pricing defensible, and does the base case survive without heroic assumptions? Entry pricing dictates how hard the commercial plan has to work, a point worth reading alongside how entry multiples shift where returns have to come from.
- Add-on: commercial fit, cross-sell reality, channel overlap, and whether combined go-to-market is additive or cannibalistic.
- Carve-out: can the division stand alone commercially once the parent’s brand, salesforce, and shared accounts are gone? This is where orphaned divisions either become standalone value or quietly lose their pipeline, a dynamic covered in this piece on corporate carve-outs and standalone value.
- Growth equity minority: less about downside protection, more about whether the growth curve compounds. The distinction between growth equity and buyout return engines should shape what the commercial read prioritizes.
Ask the firm to write the scope back to you in the language of your thesis. If they cannot restate why you are buying this business, they will not know which commercial questions matter most.
4. Judge the firm on its access plan, not its logo
The single biggest driver of quality in commercial diligence is access: how many real customer and channel conversations the firm will run, with whom, and how they will get to them. A polished brand with a thin primary program will lose to a smaller specialist with fifty structured interviews.
When you evaluate a proposal, interrogate the access plan directly:
- How many primary interviews, and of what type? Current customers, churned customers, lost prospects, and channel partners should all be represented. Current-customer-only programs produce flattering, useless results.
- Who conducts them? Senior operators who can probe, or junior analysts reading a script?
- How is bias controlled? Management-provided reference lists are curated. Good firms build their own sample.
- What is the win/loss methodology? A disciplined win/loss program tells you more about future revenue than any market model.
Harvard Business Review’s body of work on mergers and acquisitions has long noted that deals fail more often on flawed commercial assumptions than on the numbers themselves (Harvard Business Review, M&A). Access is how a firm tests those assumptions before you pay for them.
5. Insist that the firm reads the revenue engine, not just the market
Here is where most commercial diligence stops short. A firm will confirm the market is growing and the customers are satisfied, then declare the thesis intact, without ever examining whether the target’s go-to-market machine can actually deliver the plan. That gap is where post-close surprises live.
A rigorous provider looks under the revenue engine:
- Pipeline health: coverage ratios, stage conversion, and whether the pipeline is real or aspirational.
- Sales productivity: ramp time, quota attainment, rep dependency, and how much revenue rides on one or two people.
- Data infrastructure: whether the CRM even contains reliable enough data to trust the numbers. If the CRM is a mess, every commercial metric downstream is suspect.
- Marketing contribution: whether demand is manufactured repeatably or arrives by referral and luck.
This is where commercial and technical scope overlap. The reliability of the revenue data depends on the systems that hold it, which is why serious buyers pair commercial work with a look at CRM and reporting infrastructure. If you are inheriting a portfolio with fragmented systems, the questions in this guide to CRM standardization across portfolio companies and this one on what to ask a RevOps consultant will tell you whether the commercial numbers you were shown can even be trusted.
When the commercial and the operational read connect, you can distinguish a business with a repeatable engine from one running on founder energy. That distinction changes the price and the 100-day plan.
6. Demand a plan-linked deliverable, not a description
A commercial due diligence report should end where the investment decision begins. If the deliverable is a description of the market and the company that stops short of a view on the plan, it failed. The output you are paying for is judgment: does the thesis hold, where are the risks, and what would you have to believe for the base case to work?
Insist the final report includes:
- An independent view on the revenue plan, tied to the sponsor’s base case, not a restatement of management’s forecast.
- A ranked commercial risk register with the two or three items most likely to break the thesis, and the evidence behind each.
- A pricing-relevant read: what the commercial findings imply for value, even though the firm will not give you a valuation.
- A bridge into the value-creation plan: the commercial upside the sponsor can actually capture, framed for the first 100 days.
McKinsey’s research on private capital has repeatedly stressed that the operating teams inheriting these assets need diligence that translates into an executable plan, not a static assessment (McKinsey private capital research). The report should be usable by the operating partner on Day 1, not filed and forgotten after close.
7. Test how the firm classifies value it claims to find
A weak commercial read tells you the business could grow. A strong one tells you which kind of growth it is looking at and how confident it is in each. Sloppy firms present enabled or aspirational upside as if it were already in hand. That is how a base case gets inflated.
Push the firm to classify what it finds:
- Already realized: revenue the business is booking today, evidenced in the data.
- Run-rate: what current bookings annualize to.
- Forecast: what the plan projects, and what has to be true for it to happen.
- Enabled: upside that becomes available only with investment the sponsor has not yet committed.
- Risk avoided: revenue protected by fixing a commercial weakness.
If a firm blends these together, the deck reads more impressive and the underwriting gets more dangerous. The discipline of separating what is real from what is hoped is the whole point of independent commercial work. A provider that resists this classification is telling you something about how it thinks.
8. Check the firm’s independence and incentive alignment
The most valuable commercial read is one that will tell you to walk away. That means the firm’s incentive must be to be right, not to bless the deal. Some providers, particularly those attached to a broader advisory or transaction fee, have a quiet interest in the deal proceeding. Others price and structure their work so that a “no” is a perfectly acceptable outcome.
Ask directly:
- Is any part of the fee contingent on the deal closing? If so, discount the objectivity accordingly.
- Will they put a negative view in writing and defend it in front of your IC? The ones who hesitate are the ones who soften findings to keep clients happy.
- What is their record of red-flagging deals? A firm that has never killed a thesis is either lucky or accommodating.
The Harvard Law School Forum on Corporate Governance has covered the governance expectations around diligence quality and independence in depth (Harvard Law School Forum on Corporate Governance). For an operating partner, independence is not a compliance nicety. It is the difference between diligence that protects capital and diligence that rubber-stamps it.
9. Weigh sector depth against process rigor
There is a real tension between hiring a firm that knows your sector cold and one that runs a disciplined, unbiased process. The ideal has both. In practice you often choose, and the right choice depends on the asset.
When sector depth wins
Highly technical or regulated markets, niche B2B categories, or businesses where the buying process is opaque to outsiders. Here, a generalist will miss the questions that matter because they do not know the category’s failure modes. Sector specialists get to signal faster.
When process rigor wins
Markets you already understand, or where the risk is that a sector insider will import received wisdom instead of testing this specific target. Here, a rigorous outside-in process with a clean sample and disciplined win/loss beats familiarity.
PitchBook and S&P Global Market Intelligence both maintain sector-level deal and market data that a competent firm should already be working from (PitchBook research and data; S&P Global Market Intelligence). The question is not whether they have the data, it is whether they interpret it against your specific target rather than the sector average.
10. Scope the commercial read alongside the technical and ESG read
Commercial diligence does not stand alone. In technology-enabled businesses, the commercial thesis often depends on product roadmap, platform scalability, and the reliability of the systems that produce the revenue data. That is why serious buyers run commercial and technology due diligence as connected workstreams rather than silos. A commercial finding that “the product wins on features” is only as good as the technical read on whether those features are maintainable.
The same connective logic applies to ESG, where the task is separating value-relevant risk from box-ticking. This piece on ESG in diligence and value-relevant risk is worth reading if your firm’s process treats ESG as a commercial input rather than a compliance appendix. Certain ESG factors, like regulatory exposure or customer sentiment, are commercial risks in disguise.
When you scope the engagement, make explicit which questions belong to commercial, which to technical, and where the two must hand off. Ambiguous boundaries produce gaps, and gaps in diligence become surprises after close. If a firm cannot describe how its work connects to the technical and operational workstreams, it will produce an isolated deck that no one integrates.
11. Read the firm’s numbers the way you read a fund’s numbers
An operating partner should apply the same skepticism to a commercial report’s confidence claims that they apply to a fund’s performance figures. A firm that presents a single confident market-growth number without a range or a source is doing the same thing a manager does when they quote gross IRR without net or DPI. The discipline of reading past the headline number, covered in this piece on reading IRR, MOIC and DPI without being fooled, applies directly to commercial evidence.
When a firm hands you a finding, ask what it is based on, how large the sample was, and what the confidence interval looks like. Preqin and Private Equity International both publish the kind of market-level context a rigorous provider triangulates against rather than accepting a single point estimate (Preqin alternative assets data; Private Equity International). The best firms show their working. The weakest present a number and hope you do not ask.
12. Fit the commercial read to your hold thesis
The horizon changes what the commercial diligence has to prove. A three-year flip needs a commercial read that confirms near-term durability and a clear exit narrative. A longer hold, or a continuation vehicle, needs the read to underwrite compounding growth several years out, which is a harder and more important test.
As hold periods extend, the burden of value creation moves from the deal team to the operator, a shift explored in this piece on how longer holds move the value-creation burden to the operator. If you are underwriting a longer hold or a GP-led continuation vehicle, the commercial read must go deeper on the durability of the demand engine and the repeatability of the growth playbook, because you will be the one operating against it for years. Tell the firm your horizon and make them scope to it. A read built for a quick flip will not serve a business you plan to hold and compound.
13. A buyer’s checklist for hiring the firm
Before you sign the engagement letter, run the provider against this list. If a firm cannot pass most of it, keep looking.
- Decision-linked scope: the firm can restate the two or three decisions the work must inform, in your thesis language.
- Primary access plan: a concrete number of interviews across current, churned, and lost customers plus channel, with senior interviewers.
- Own sample, not management’s list: the firm builds its reference base to control for curation bias.
- Revenue-engine read, not just market study: pipeline, sales productivity, and data reliability are in scope.
- Value classification discipline: findings separated into realized, run-rate, forecast, and enabled.
- Plan-linked deliverable: an independent view on the base case and a ranked commercial risk register.
- Independence: no close-contingent fee, and a willingness to put a “no” in writing.
- Right depth-vs-rigor call: sector specialists where the market is opaque, process rigor where you already know the space.
- Connected workstreams: explicit handoffs to technical and operational diligence, no silos.
- Horizon fit: the read is scoped to your hold thesis, not a default flip.
- Shows its working: sources, sample sizes, and confidence ranges on the numbers it presents.
- Day 1 usable: the output flows into the value-creation plan, not into a drawer.
BCG’s work on principal investors and private equity underlines that the diligence that pays off is the diligence that connects the outside-in market view to an executable operating plan (BCG principal investors & private equity). That connection is the whole test. A firm that produces analysis you cannot act on has not done commercial due diligence. It has produced a document.
14. What good looks like when it lands
The right commercial due diligence firm changes how you walk into the investment committee. Instead of restating the CIM, you carry an independent view: here is where the demand is real and where it is fragile, here is the concentration risk management underplayed, here is what the base case requires and whether the evidence supports it. You know before you commit capital whether you are buying a repeatable engine or a personality-driven growth story that resets the day the founder leaves.
The wrong firm gives you a confident deck that ages badly. The cost of that mistake is not the fee. It is a mispriced entry, a value-creation plan built on a shaky commercial premise, and an operating team spending the first year disc